BE is the latest research achievement in the direction of genome editing, it takes single nucleotide variations into DNA or RNA in living cells, which could take point mutations in DNA without generating double-strand break (DSB). At present, cytosine base editor (CBE) and adenine base editor (ABE) have been constructed. CBE can convert the target site C>G of four bases A, T, C, and G in DNA to T>A, while ABE can mutate the target site A>T to G>C. If prime editing is likened to a missile, then BE is like a sniper bullet. BE can directly change a specific base at a specific position in the genome, and only change a single target base without affecting other bases. It is characterized by single-site mutation and targeting. BE is achieved with the help of DNA and RNA base editors, which allow the introduction of point mutations at specific sites in DNA or RNA.
Fig.1 Cytosine and adenine base editors. (Antoniou, et al., 2021)
Base editors intervene at the most basic level with high efficiency and precision. Single base changes are a versatile way of precisely changing the glycogene, enabling many different possible editing strategies. The services we provide include but are not limited to:
Fig.2 An example of base editing in mammalian cells. (CD BioGlyco)
CD BioGlyco has invested a lot of resources in the research and development of gene editing for several years and has accumulated a wealth of experience in relevant technologies. We hope that our technology and services help you achieve breakthroughs. For more information, please feel free to contact us.
Reference: